Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

OTCQX:MRVFF - Post Discussion

Nuvo Pharmaceuticals Inc > Dead money?
View:
Post by MrW0nderfu1 on Jan 02, 2020 8:54pm

Dead money?

What's next for Nuvo? What will get this moving again? Volume is sad but this compnay seems to have a decent story...
Comment by lscfa on Jan 02, 2020 9:04pm
pre-announcing some Q4 numbers before the deadline of April 1 would help.     
Comment by MrW0nderfu1 on Jan 02, 2020 9:18pm
Have they done this in the past? That would give it a boost... 
Comment by ValueCap on Jan 03, 2020 5:28pm
Here are some things that can get the stock moving in my opinion. Resultz US distribution deal. Suvexx green light from health Canada coming in Q1. Pensaid 2% European approval in Q1. Continued earnings performance. Continued growth of blexten and cambia
Comment by ValueCap on Jan 03, 2020 7:17pm
Would also be nice if another institutional buyer saw the story and bought in as well. I think there are two big holders. Polar and Norrep.
Comment by MrW0nderfu1 on Jan 03, 2020 7:39pm
Thank you for the information. Thinking of increasing my position. Cheers!
Nuvo Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities